series-c-plus
Stage
2018
Founded
1
Investors
About
Anaptys Royalty Co manages financial collaborations and royalties for pharmaceutical products developed with partners GSK and Vanda, having spun off its biopharma operations into a separate company in April 2026.
Explore Anaptys Royalty Co's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.